Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB5243

Introduced
9/25/24  

Caption

Cannabinoid Safety and Regulation Act

Impact

This bill will impact various facets of state law, primarily by standardizing how cannabinoid products are manufactured, marketed, and sold across states. Importantly, while it sets federal standards, it preserves the authority of states and tribes to enact stricter regulations regarding the sale, distribution, and taxation of these products. This dual approach is intended to balance federal oversight with local control, allowing for regional variations based on community needs. For example, states can still enforce additional health, fire safety, or environmental measures without conflicting with federal standards, thus promoting public safety while ensuring compliance.

Summary

SB5243, known as the Cannabinoid Safety and Regulation Act, aims to establish comprehensive federal guidelines and regulations concerning cannabinoid products. This legislation seeks to ensure that cannabinoid products meet specific standards regarding safety, efficacy, and labeling. Most notably, the bill introduces civil penalties for violations of these regulations, setting fines for both minor and egregious offenses in the manufacture and distribution of cannabinoid products. The maximum penalty can reach up to $15,000 for each violation, with potential cumulative penalties in the millions for multiple breaches.

Contention

Noteworthy points of contention around SB5243 involve concerns that the federal regulations might supersede state laws, particularly regarding labeling and local taxation of cannabinoid products. Critics argue that this centralization could limit states' abilities to tailor regulations to local conditions, thus potentially undermining public health initiatives aimed at preventing underage use and addressing specific community health issues associated with cannabis. Furthermore, the penalties imposed for non-compliance have raised concerns among manufacturers about the viability and financial implications of their businesses, which signifies ongoing debates about the balance of regulation and industry growth.

Companion Bills

No companion bills found.

Similar Bills

HI HB1359

Relating To Hemp.

NJ S1699

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

NJ A5198

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

NJ A1890

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

NJ S3470

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

ND HB1203

Definitions of medical marijuana products.

ND SB2102

Fingerprint-based criminal history record checks for the department of health and human services, and compassion centers.

MN HF773

Regulation of concentration and conversion of cannabinoids derived from hemp provided, regulation of cannabinoid transportation and testing provided, licensing of manufacturers and distributors provided, cannabis product regulations provided, enforcement of regulations provided, licensing guidelines established, gross receipts tax established, criminal penalties established, exclusive liquor stores authorized to sell products, and money appropriated.